Point of Care | Canada Respiratory Season | Roche

Unpredictable disease fluctuations during the respiratory season make it difficult to differentiate between COVID-19, Flu, and RSV. And many cases go under reported. In a recent COVID-19 study, more than 1 in 2 patients were unaware of any recent Omicron variant infection.8

For patients who feel sick, experienced symptoms may be nonspecific so it’s difficult to diagnose based on signs and symptoms alone. The challenge of differential diagnosis may lead to delays in clinical decision making, patient care and initiation of appropriate treatment and infection control measures. It is essential to accurately diagnose patients quickly to ensure they receive the best and most appropriate care.

Respiratory testing solutions for every care setting

Get an early look at the solutions designed to help address your lab's needs now and well into the future.

Roche has testing solutions where and when it matters

Reference:
8. Young, S, et al. Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity. JAMA Netw Open. 2022;5(8):e2227241. doi:10.1001.

Connect with us

LEARN MORE ABOUT:

Gold-standard PCR diagnostics systems

ROCHE REPRESENTATIVE

Connect with a Roche representative on solutions for your lab and upcoming product launches.